Thomas Schinecker, Roche CEO (Georgios Kefalas/EPA-EFE/Shutterstock)
September 11, 2023 11:39 AM EDT
R&D
Pharma

Roche CEO out­lines new R&D strat­e­gy af­ter years of late-stage tri­al fail­ures

Max Gelman

Senior Editor

New Roche CEO Thomas Schi­neck­er is im­ple­ment­ing a re­fined R&D strat­e­gy for the sprawl­ing Swiss con­glom­er­ate in the wake of sev­er­al re­cent late-stage fail­ures. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times